Sociedad Americana de Hirudoterapia

Medicinal leech therapy in pain syndromes: a narrative review

Koeppen D, Aurich M, Rampp T (2013) · Wiener Medizinische Wochenschrift · n=0

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Knee Osteoarthritis

Study Profile

Design
narrative review of medicinal leech therapy efficacy across pain-relevant clinical conditions (Biebertaler Blutegelzucht GmbH, Germany)
Sample size (n)
0
Intervention
Synthesis of published clinical studies and case reports of medicinal leech therapy in pain syndromes - osteoarthritis, lateral epicondylitis, thrombophlebitis, varicose veins, edema, hematoma, and other indications
Comparator
No quantitative comparator - narrative synthesis only
Primary endpoint
Qualitative assessment of leech therapy analgesic effects across pain syndromes
Primary result
Narrative consolidation: pain relief from leech therapy is described as rapid, effective, and long-lasting across multiple chronic-pain indications; mode of action attributed to anti-inflammatory, thrombolytic, anti-coagulant, and blood/lymph circulation-enhancing properties of leech saliva; specific analgesic substance not yet identified
Follow-up duration
not applicable (narrative review)

Key Findings

  • Comprehensive narrative review of leech therapy in pain syndromes by the principal European medical leech supplier (Biebertaler Blutegelzucht)
  • Synthesizes evidence across osteoarthritis, lateral epicondylitis, thrombophlebitis, varicose veins, edema, and hematoma
  • Concludes that leech-mediated analgesia is rapid, effective, and long-lasting in many conditions
  • Mechanistic discussion emphasizes anti-inflammatory, thrombolytic, anti-coagulant, and circulation-enhancing properties
  • Notes that the specific analgesic compound in leech saliva remains unidentified - hypothesis-generating

Limitations

  • Narrative review only - no formal systematic search or quality assessment
  • Author affiliation with leech-supplier company creates COI concern
  • Includes case reports and uncontrolled studies alongside RCTs without weighting
  • No GRADE rating provided
  • Not a primary source of evidence - useful as context but not as outcome evidence

Clinical Implications

Koeppen 2013 is the most-cited narrative review of leech therapy in pain syndromes and is widely referenced in European integrative-medicine practice. It is most useful to clinicians as a contextual overview rather than a primary evidence source. The author's affiliation with the principal European leech supplier (Biebertaler Blutegelzucht) should be disclosed to readers but does not invalidate the underlying citations. For ASH editorial purposes, this review is cited only as a mechanism-and-overview reference; quantitative effect estimates should come from underlying RCTs (Michalsen 2003, Andereya 2008, Stange 2011/2012, Lauche 2014 meta-analysis).

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.